Open Access Highly Accessed Pre-publication history

Follow-up of phase I trial of adalimumab and rosiglitazone in FSGS: III. Report of the FONT study group

Alexandra Peyser, Nathaniel MacHardy, Freya Tarapore, Jacqueline MacHardy, Leslie Powell, Debbie S Gipson, Virginia Savin, Cynthia Pan, Theresa Kump, Suzanne Vento and Howard Trachtman*

BMC Nephrology 2010, 11:2  doi:10.1186/1471-2369-11-2

Pre-publication versions of this article and reviewers' reports

Original Submission - Version 1 Manuscript 02 Oct 2009
Reviewer's Report Pankaj Hari 16 Nov 2009
Reviewer's Report Therese Jungraithmayr 20 Nov 2009
Resubmission - Version 2 Manuscript Author's comment 02 Dec 2009
Resubmission - Version 3 Manuscript Author's comment 03 Dec 2009
Reviewer's Report Pankaj Hari 21 Dec 2009
Reviewer's Report Therese Jungraithmayr 22 Dec 2009
Resubmission - Version 4 Manuscript Author's comment 15 Jan 2010
Editorial acceptance 20 Jan 2010
Published 29 Jan 2010